Infleqtion | $100,000,000 | (Jun 3, 2025)
Trustifi | $25,000,000 | (Jun 3, 2025)
LuminX | $5,500,000 | (Jun 3, 2025)
Certified by Founder
Lodge
Endogenex
start up
United States
- PLYMOUTH, MN
- 26/06/2024
- Series C
- $88,000,000
Endogenex, in partnership with Mayo Clinic, aims to revolutionize treatment options for individuals with type 2 diabetes (T2D). Endogenex’s innovations focus on resetting the body’s metabolic signaling system by harnessing its natural regenerative capabilities to improve metabolic function. Through the development of the ReCET™ System and the novel application of precise, controlled, non-thermal pulsed electric fields, Endogenex is establishing a new era in treatment options for people living with T2D, helping patients regain control of their blood glucose levels and slow disease progression.
Endogenex is a privately held, clinical-stage company based in Minneapolis, MN.
- Industry Medical Equipment Manufacturing
- Website https://www.endogenex.com/
- LinkedIn https://www.linkedin.com/company/endogenexinc/
Archil | $6,700,000 | (Jun 3, 2025)
Limited | $7,000,000 | (Jun 3, 2025)
Dexari | $2,300,000 | (Jun 3, 2025)
Heron Power | $38,000,000 | (Jun 3, 2025)
Volteras | $11,100,000 | (May 30, 2025)
ROXFIT | $1,077,281 | (May 30, 2025)
Dream Park Immersive | $1,100,000 | (May 30, 2025)